| Name | Title | Contact Details |
|---|
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
Georgetown Health Care Ctr is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Robins Landing Senior Living is an assisted living facility in New Berlin that provides compassionate care to residents. They strive to create a warm and welcoming home-like atmosphere that is safe, secure, and uplifting.
Helen Keller Hospital is a not-for-proft, community hospital in Sheffield, AL. An acute care facility, Helen Keller Hospital is licensed to operate 185 beds. History Colbert County and the City of Sheffield opened a Hospital, March 22, 1921. At the time, this was called Colbert County Hospital. It is now known as Helen Keller Memorial Hospital, part of the Colbert County Healthcare Authority. Other healthcare entities under the umbrella the Colbert County Healthcare Authority include Red Bay Hospital, North Alabama Sleep Disorders Center and Northwest Practice Management. On May 21, 1979, the name of the hospital was changed to Helen Keller Hospital in honor of that great lady and world-renowned humanitarian. The continued growth of the Northwest Alabama Healthcare Authority is a result of the dedication of the Board of Trustees, the citizens of Colbert County and the hospital employees, who deliver excellent patient care. Helen Keller Hospital is fully accredited by the Joint Commission on Accreditation of Hospitals assuring the finest in medical care by the process of review inspection and updating. The Authority is governed by a nine-member Board of Trustees from Colbert County appointed by the County Commission serving in staggered six-year terms. While the Board of Trustees is ultimately responsible for the operation of the Authority, the details are delegated to the Authority President.
The Physicians Eye Care Center of America is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.